| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) | 
|---|
| 11/06/2013 | CN102050747B Preparation method of organic onium tetrafluoroaluminate and method for preparing aluminum oxide through low temperature electrolysis | 
| 11/06/2013 | CN101935285B Hexafluoroaluminate of organic onium, and preparation method and application thereof | 
| 11/06/2013 | CN101918417B Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same | 
| 11/06/2013 | CN101914112B Method for preparing butafosfan | 
| 11/06/2013 | CN101460059B Compound for antimicrobial therapy for bacterial infections and its pharmaceutical uses | 
| 11/06/2013 | CN101076533B Compounds and methods for the treatment of cancer | 
| 11/05/2013 | US8575246 Flame-retardant thermoplastic resin composition and molded article | 
| 11/05/2013 | CA2740508C Improved process for the preparation of carbapenem using carbapenem intermediates and recovery of carbapenem | 
| 11/05/2013 | CA2481202C Functionalized ionic liquids, and methods of use thereof | 
| 10/31/2013 | WO2013163576A1 Pantothenate derivatives for the treatment of neurologic disorders | 
| 10/31/2013 | WO2013161816A1 Amine compound and use thereof for medical purposes | 
| 10/31/2013 | WO2013160206A1 Composition for a lithium battery including at least one specific fluorinated compound as an organic solvent and at least one lithium salt | 
| 10/31/2013 | WO2013159229A1 Silanyloxyaryl phosphine ligand and uses thereof in c-n cross-coupling | 
| 10/31/2013 | US20130289117 Hydroxyl compounds and compositions for cholesterol management and related uses | 
| 10/31/2013 | US20130289002 Gyrase and topoisomerase iv inhibitors | 
| 10/31/2013 | US20130289001 Pantothenate derivatives for the treatment of neurologic disorders | 
| 10/31/2013 | US20130288080 Perfluoropolyether containing lubricants with mixed end groups | 
| 10/31/2013 | US20130287749 Formulation for snail baits comprising organophosphonic acids, metal salts and methiocarb | 
| 10/31/2013 | US20130287671 Multimetallic assembly, methods of making multimetallic assembly, methods of oxidizing water, methods of o-atom transfer catalysts, and methods of carbon dioxide reduction | 
| 10/30/2013 | EP2657242A2 Amphiphilic cyclic phosphazene trimer, hydrophobic pharmaceutical formulation micellized by amphiphilic cyclic phosphazene trimer, and preparation methods thereof | 
| 10/30/2013 | EP2657241A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient | 
| 10/30/2013 | EP2655384A2 Oligomeric phosphonates and compositions including the same | 
| 10/30/2013 | EP2655383A2 Hyperbranched oligomeric phosphonates and compositions including the same | 
| 10/30/2013 | EP2655317A1 Liquid composition comprising ethylenediamine disuccinic acid salt | 
| 10/30/2013 | EP2655305A1 Process for telomerization of butadiene using a mono-orthoalkoxy substituted catalyst | 
| 10/30/2013 | CN103374041A Lewis acid mediated synthesis of cyclic esters | 
| 10/30/2013 | CN103374040A Alcohol soluble cathode buffer layer molecular material containing triaryl phosphonium oxygen and nitrogen heterocyclic functional groups as well as synthetic method and application thereof | 
| 10/30/2013 | CN103374039A Synthesis method of tenofovir | 
| 10/30/2013 | CN103374038A Preparation method of antiviral medicine | 
| 10/30/2013 | CN103374037A Crystallization purification method for carbapenem compound intermediates | 
| 10/30/2013 | CN103374036A Synthesis process of vitamin C derivative | 
| 10/30/2013 | CN103374035A Method for microwave synthesis of organic phosphine-functionalized imidazolium-based ionic liquid | 
| 10/30/2013 | CN103374034A Organic phosphine-functionalized pyridine-based ionic liquid and preparation method thereof | 
| 10/30/2013 | CN103374033A Functionalized quaternary phosphonium salt ionic liquid of organic phosphine and preparation method thereof | 
| 10/30/2013 | CN103374032A Organic phosphine-functionalized quaternary ammonium salt-based ionic liquid and preparation method thereof | 
| 10/30/2013 | CN103374031A Method for preparing bis(4-carboxyphenyl) phenyl phosphine oxide (BCPPO) | 
| 10/30/2013 | CN103374030A Method for preparing glufosinate-ammonium and preparation method for intermediate thereof | 
| 10/30/2013 | CN103374029A Preparation method of fatty alcohol polyoxyethylene phosphate ester potassium salt | 
| 10/30/2013 | CN103374028A Preparation method of triethyl phosphate | 
| 10/30/2013 | CN102153483B Axial chirality vicinal diamine compound and preparation method thereof | 
| 10/30/2013 | CN101501050B Alpha-amino acid phosphonic acid compounds, method of preparation and use thereof | 
| 10/29/2013 | US8569515 Directed synthesis of oligophosphoramidate stereoisomers | 
| 10/29/2013 | US8569484 Heterocyclic urea derivatives and methods of use thereof | 
| 10/29/2013 | US8569478 Modified 4′-nucleosides as antiviral agents | 
| 10/29/2013 | US8569270 Diphenyl sulfide derivatives and medicines containing same as active ingredient | 
| 10/29/2013 | US8568771 Use of microvesicles (MVs) derived from stem cells for preparing a medicament for endo/epithellal regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods | 
| 10/29/2013 | US8568701 Cationic synthetic polymers with improved solubility and performance in phosphate surfactant-based systems and use in personal care and household applications | 
| 10/29/2013 | CA2594902C Process for the manufacture of aminopolyalkylenephosphonic acid compounds | 
| 10/24/2013 | WO2013158597A1 (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators | 
| 10/24/2013 | WO2013157383A1 Method for producing 2,2-bis(4-hydroxyphenyl)hexafluoropropane-quaternary phosphonium salt | 
| 10/24/2013 | WO2013155600A1 Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors | 
| 10/24/2013 | WO2013087792A3 Process and catalyst for the electrochemical reduction of carbon dioxide | 
| 10/24/2013 | WO2002094883A3 One-step process for the preparation of halide-free hydrophobic salts | 
| 10/24/2013 | US20130281708 Process for the Production of 2-Amino-5-Fluorothiazole | 
| 10/24/2013 | US20130281688 Unsaturated fatty alcohol compositions and derivatives from natural oil metathesis | 
| 10/24/2013 | US20130281664 Novel ruthenium complexes and their uses in processes for formation and/or hydrogenation of esters, amides and derivatives thereof | 
| 10/24/2013 | US20130281492 Novel oxazolidinone derivatives | 
| 10/24/2013 | US20130281407 Novel phosphonic acid compounds as inhibitors of serine proteases | 
| 10/24/2013 | US20130281406 Thiazole derivatives and their use as p2y12 receptor antagonists | 
| 10/24/2013 | US20130281365 Fused aromatic ptp-1b inhibitors | 
| 10/23/2013 | EP2651961A1 Protein affinity tag and uses thereof | 
| 10/23/2013 | EP2651957A1 Phosphorous derivatives as chemokine receptor modulators | 
| 10/23/2013 | EP2651878A1 Cyclohexane compounds and their use as antibiotics | 
| 10/23/2013 | EP2651448A2 Functionalized polymers | 
| 10/23/2013 | CN103370329A Amphiphilic cyclic phosphazene trimer, hydrophobic pharmaceutical formulation micellized by amphiphilic cyclic phosphazene trimer, and preparation methods thereof | 
| 10/23/2013 | CN103370328A Method for producing biphephos | 
| 10/23/2013 | CN103370327A Method for the purification of biphephos | 
| 10/23/2013 | CN103370326A Phosphorous derivatives as chemokine receptor modulators | 
| 10/23/2013 | CN103370102A Novel oxime derivatives as sphingosine 1-phosphate (S1P) receptor modulators | 
| 10/23/2013 | CN103361171A Method for preparing rice bran oil, rice bran protein and phytin from rice bran | 
| 10/23/2013 | CN103360626A Preparation method of industrial mould inhibitor compounding liquid containing 1% to 5% of OBPA (10,10'oxybis-phenoxarsine) | 
| 10/23/2013 | CN103360625A Flame retardant tetra (O-methyl-phenyl phosphinic) glycoluril compound and preparation method therefor | 
| 10/23/2013 | CN103360624A Flame retardant tetra (O, O-diethyl phosphoryl) glycoluril compound and preparation method therefor | 
| 10/23/2013 | CN103360606A Halogen-free organophosphate fire retardant and its preparation method | 
| 10/23/2013 | CN103360605A Hyperbranched polyphosphate amide ester as well as preparation method and application thereof | 
| 10/23/2013 | CN103360567A Flame retardant flexible polyurethane foaming plastic | 
| 10/23/2013 | CN103360566A Flame retardant rigid polyurethane foaming plastic | 
| 10/23/2013 | CN103360426A Phosphoinositide compounds, as well as preparation method and application thereof | 
| 10/23/2013 | CN103360425A Synthesis method of tenofovir disoproxil and fumarate thereof | 
| 10/23/2013 | CN103360424A Structure of multi-metal phosphomolybdate organic-inorganic hybrid and preparation method | 
| 10/23/2013 | CN102553646B Chiral diamine diphosphine metal compound catalysts as well as preparation method and application thereof | 
| 10/23/2013 | CN101845057B Substituted phenol for methylal phosphate anesthetic and sedative drugs and preparation method thereof | 
| 10/22/2013 | US8563716 Compositions and methods for inhibition of the JAK pathway | 
| 10/22/2013 | US8563661 Phosphorus-containing compounds useful for making halogen-free, ignition-resistant polymers | 
| 10/22/2013 | US8563637 Alkylphenol free-liquid polymeric phosphite polymer stabilizers | 
| 10/22/2013 | US8563569 Compositions and methods for inhibition of the JAK pathway | 
| 10/22/2013 | US8563534 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis | 
| 10/22/2013 | CA2550642C Oligonucleotide compound and method for treating nidovirus infections | 
| 10/17/2013 | WO2013124874A3 Glucose derivatives bound to arsenic for use in the treatment of tumour | 
| 10/17/2013 | US20130274499 Synthesis of 2,4-Pyrimidinediamines | 
| 10/17/2013 | US20130274484 Aromatic compounds bearing at least one phosphonate or phosphinate group, preparation method and uses thereof | 
| 10/17/2013 | US20130274479 Aminohydroxylation of alkenes | 
| 10/17/2013 | US20130274465 Adsorption of immunopotentiators to insoluble metal salts | 
| 10/17/2013 | US20130274230 (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators | 
| 10/17/2013 | US20130274212 Sesterterpene Compounds and Use Thereof | 
| 10/17/2013 | US20130274174 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use | 
| 10/16/2013 | EP2649084A1 Novel derivatives of oxazaphosphorines that are pre-activated, use and method of preparation | 
| 10/16/2013 | EP2648735A2 Granzyme b inhibitor compositions, methods and uses for promoting wound healing | 
| 10/16/2013 | CN103351408A Flame-retardant liquid crystal ionomer and synthesis method thereof | 
| 10/16/2013 | CN103351407A Novel crystal form of cocarboxylase tetrahydrate |